What question did this study set out to answer?

This research aims to explore the remodeling of the myocardium and identify potential therapeutic targets in collagen pathways.

March 1, 2003Current Drug Targets - Cardiovascular & Hematological Disorders

Remodeling of the Myocardium and Potential Targets in the Collagen Degradation and Synthesis Pathways

Q: What is the clinical evidence from this study?

Study design: Review. Population: Myocardial remodeling in hypertension, heart failure, and myocardial infarction. Intervention: Antifibrotic agents.

View Full Paper

Ask AI

Bookmark

Key result

Antifibrotic agents targeting collagen synthesis and degradation pathways represent promising strategies for treating myocardial remodeling in cardiovascular diseases.

Design

Review

Authors

BJBodh I. JugduttUniversity of Alberta

Discussion

Member takes

Implication

Antifibrotic collagen targeting may aid remodeling management; leaves open clinical adoption pending randomized trials.

Key Points

This research aims to explore the remodeling of the myocardium and identify potential therapeutic targets in collagen pathways.
Focus on the role of fibroblasts and collagen in heart diseases.
Examine potential antifibrotic agents targeting collagen synthesis and degradation.
Discuss strategies for localized delivery of interventions to specific heart regions.
Excessive collagen deposition leads to left ventricular dysfunction and poor outcomes in cardiovascular diseases.
Pathological fibrosis is a significant concern in both heart failure and the aging heart.
Future strategies may allow targeted therapies to specific cardiac regions, improving localized treatment.

PICO

Population

Myocardial remodeling in hypertension, heart failure, and myocardial infarction

Intervention / Comparator

Antifibrotic agents

The review highlights the critical role of the extracellular collagen matrix in myocardial remodeling and identifies targeted antifibrotic therapies as a promising future strategy for managing heart failure and post-myocardial infarction healing.

Limitations

Designing approaches that separately target the infarct zone and non-infarct zone is challenging because reparative fibrosis is essential for healing.

Cite This Study

Bodh I. Jugdutt (2003) conducted a review in Myocardial remodeling in hypertension, heart failure, and myocardial infarction. Antifibrotic agents was evaluated. Antifibrotic agents targeting collagen synthesis and degradation pathways represent promising strategies for treating myocardial remodeling in cardiovascular diseases.

synapsesocial.com/papers/6a1fcb2e66f4632d4f6b45df https://doi.org/10.2174/1568006033337276

View Full Paper

Ask AI

Bookmark

Remodeling of the Myocardium and Potential Targets in the Collagen Degradation and Synthesis Pathways

Discussion

Member takes

Implication

Key Points

PICO

Limitations

Cite This Study

Remodeling of the Myocardium and Potential Targets in the Collagen Degradation and Synthesis Pathways

Discussion

Member takes

Implication

Key Points

PICO

Limitations

Cite This Study

Also Consider

Also Consider